Skip to content
Abierto
Menu

Special notice

Notice of Intent to Sole Source: Human Induced Pluripotent Stem Cell-derived Cells

CDRH-2024-122548

Food and Drug Administration, FDA Office of Acq Grant SVCS. In-Vitro Diagnostic Substance Manufacturing.

View on SAM.govMarkdown

Awarded

Fujifilm Cellular Dynamics, Inc.

$26,680.00 obligated so far on USAspending

Description

As published on SAM.gov.

Please see attached document titled 'Notice of Intent to Sole Source_CDRH-2024-122548'.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Fujifilm Cellular Dynamics, Inc.
UEI
H1LMMSH2CRJ5
CAGE
474X4
Vendor location
Madison, WI
Contract
75F40124P00124, purchase order
Obligated
$26,680.00
Actions
1 between May 8, 2024 and May 8, 2024
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Human Induced Pluripotent Stem Cell-Derived Cells (Hipscs)
Match
solicitation number CDRH2024122548 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 18, 2024

    Special notice

    Due March 28, 2024 at 10:00 AM EDT. SAM.gov, notice 6538ee9b72724c36b7f83739b63cc814

Points of contact

Also open from this buyer